However, a 27% reduction of mortality with a marginally statistically significant result [hazard ratio (HR) = 0.73, 95% CI 0.52–1.03] was also presented by the trial [ 19 ].
← all excerpts
Evaluating Clinical Efficacy of Antiviral Therapy for COVID-19: A Surrogate Endpoint Approach.
1
—
—